申请人:Lopez-Rodriguez Maria Luz
公开号:US20090036455A1
公开(公告)日:2009-02-05
Novel substituted arylpiperazine derivatives with activity as 5-hydroxytryptamine 1A (5-HT
1A
) receptor subtype ligands, to their stereochemical isomers, methods of their preparation, and to their use and to pharmaceutical compositions containing them for the treatment of Parkinson disease, cerebral damage by thromboembolic ictus, craneoencephalic traumatisms, depression, migraine, pain, psychosis, anxiety disorders, aggressive disorders or urinary tract disorders.
小说替代了具有5-羟色胺1A(5-HT1A)受体亚型配体活性的芳基哌嗪衍生物,包括它们的立体化异构体、制备方法以及它们在治疗帕金森病、血栓栓塞性卒中引起的脑损伤、颅脑外伤、抑郁症、偏头痛、疼痛、精神病、焦虑症、攻击性障碍或泌尿道障碍的药物组成物中的使用。